NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Navco Pharmaceuticals Inc. has been granted a Health Canada license for a nanoparticle-based antimicrobial cream, expanding their product range with a novel skin protection option. The cream, which uses nano-silver for its germ-fighting properties, offers moisturizing benefits and is an alcohol-free alternative to sprays. It aligns with the growing dermocosmetics market, which is projected to see significant growth over the next decade.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.